Preterm labor and birth: where are we now?
Lyndon
Audrey
A
UCSF School of Nursing Doctoral Program, San Francisco, Calif, USA. audrey.lyndon@ucsf.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001510:Bed Rest; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D018890:Chemoprevention; D019317:Evidence-Based Medicine; D005260:Female; D005440:Fluid Therapy; D006301:Health Services Needs and Demand; D006801:Humans; D007752:Obstetric Labor, Premature / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D018743:Perinatal Care / Q000458:organization & administration*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011256:Pregnancy Outcome; D011295:Prenatal Care / Q000458:organization & administration*; D011374:Progesterone / Q000627:therapeutic use; D012307:Risk Factors; D015149:Tocolytic Agents / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D015149:Tocolytic Agents; D011374:Progesterone